D-dimer tests demand in China grows amidst COVID-19: GlobalData | Healthcare Asia Magazine

D-dimer tests demand in China grows amidst COVID-19: GlobalData

The demand, due to the monitoring of COVID-19, is seen to drive the market at a 10% CAGR between 2020 and 2025.

The D-dimer tests market in China is seeing a growing demand due to the monitoring of D-dimer levels in COVID-19 cases, setting to lead the market at a compound annual growth rate of about 10% between 2020 and 2025, according to GlobalData.

Physicians in China are preferring D-dimer tests, often used as a “biomarker” for the diagnosis conditions such as pulmonary embolism, deep vein thrombosis and disseminated intravascular coagulation,” potential prognostic marker to assess the disease severity of the COVID-19 patients,” Gundreddy Gopinadh, Medical Devices Analyst at GlobalData, said.

“In China, COVID-19 cases have grown significantly in the past few weeks and there is a growing concern this disease may spread fast and to a much wider geographic region compared to the first time it was reported in 2019,” Gopinadh said. 

He also said that the D-dimer point of care (POC) test market in China accounted for 40% of the D-dimer market in 2020. “Growing number of severe COVID-19 infected patients and the necessity for quick coagulopathy testing is expected to further boost the D-dimer POC tests market in the country.”

GlobalData said that D-dimer tests are useful in monitoring and predicting the progression of a COVID-19-related risk of a patient such as thromboembolism and cytokine stormIt is also helpful in deciding when a COVID-19 patient would require hospital admission in the first week of infection and “help in timely medical interventions.”

GlobalData also said that its Hemostasis Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact) report showed that Siemens Healthineers AG, Quidel Corp and Werfen Life Group SAU were the leading players in China in 2020

Follow the link for more news on

EMC Healthcare dan InterSystems akan meluncurkan sistem rekam medis elektronik canggih di Indonesia

Sistem ini dilengkapi dengan dokumentasi otomatis dan kode berbasis AI.

Rumah sakit swasta di Filipina diminta berhati-hati akan pengeluaran

Klaim layanan kesehatan di negara ini diperkirakan meningkat 21% tahun ini.

KTPH melacak pasien dan peralatan secara real-time

Rumah sakit milik negara Singapura ini juga berencana menggunakan gelang RFID pasif untuk melacak lokasi pasien.

Sistem otomatis mengangkut instrumen bedah di Singapura

Sistem ini mengirimkan instrumen siap pakai langsung ke meja operasi.

Island Hospital menggunakan rehabilitasi berbasis data untuk mempercepat pemulihan

Teknologi ini menyesuaikan latihan pasien dan memberikan feedback secara real-time.

Rumah Sakit didesak menutup kesenjangan dalam layanan kesehatan perempuan

Investasi yang lebih baik dalam kesehatan perempuan dapat meningkatkan perekonomian global sebesar USD 1 triliun per tahun pada 2040.

NUHCS melatih lebih banyak ahli bedah untuk implantasi katup jantung yang kurang invasif

TAVI menargetkan kondisi yang sering dimulai dengan murmur jantung.